Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -6.13% and Operating profit at -11.92% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 5.17% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -6.13% and Operating profit at -11.92% over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
4
With ROCE of 2.98%, it has a risky valuation with a 0.74 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Stock DNA
Specialty Chemicals
JPY 257,217 Million (Small Cap)
12.00
NA
0.02%
0.68
5.87%
0.65
Revenue and Profits:
Net Sales:
100,459 Million
(Quarterly Results - Jun 2025)
Net Profit:
4,565 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.81%
0%
3.81%
6 Months
11.32%
0%
11.32%
1 Year
4.77%
0%
4.77%
2 Years
10.55%
0%
10.55%
3 Years
26.9%
0%
26.9%
4 Years
26.77%
0%
26.77%
5 Years
30.62%
0%
30.62%
UBE Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.13%
EBIT Growth (5y)
-11.92%
EBIT to Interest (avg)
25.95
Debt to EBITDA (avg)
3.44
Net Debt to Equity (avg)
0.53
Sales to Capital Employed (avg)
0.76
Tax Ratio
15.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
4.66%
ROE (avg)
5.17%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.60
EV to EBIT
24.71
EV to EBITDA
9.81
EV to Capital Employed
0.74
EV to Sales
0.92
PEG Ratio
NA
Dividend Yield
0.02%
ROCE (Latest)
2.98%
ROE (Latest)
5.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
100,459.00
127,181.00
-21.01%
Operating Profit (PBDIT) excl Other Income
8,938.00
15,175.00
-41.10%
Interest
832.00
628.00
32.48%
Exceptional Items
0.00
1,189.00
-100.00%
Consolidate Net Profit
4,565.00
15,494.00
-70.54%
Operating Profit Margin (Excl OI)
29.40%
66.90%
-3.75%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -21.01% vs 9.09% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -70.54% vs 161.19% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
486,802.00
468,237.00
3.96%
Operating Profit (PBDIT) excl Other Income
45,463.00
49,158.00
-7.52%
Interest
1,730.00
1,042.00
66.03%
Exceptional Items
-29,113.00
358.00
-8,232.12%
Consolidate Net Profit
-9,215.00
29,036.00
-131.74%
Operating Profit Margin (Excl OI)
37.10%
48.00%
-1.09%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 3.96% vs -5.36% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -131.74% vs 455.96% in Mar 2024
About UBE Corp. 
UBE Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






